MGX Metagenomi Therapeutics, Inc. - Common Stock
$1,26
Fiyat · May 20, 2026
Temel veriler itibarıyla May 11, 2026
52 Haftlık Aralık
$1–$4
1% of range
Analist Derecelendirmesi
BUY
9 analysts
Fiyat Hedefi
$9
+641% upside
P/E (TTM)
-0.7
ROE
-49.6%
Net Kâr Marjı
-348.5%
MGX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.26
Piyasa Değeri
$61M
P/E (TTM)
-0.7
EPS (TTM)
$-2.36
Gelir (TTM)
$25M
Temettü Verimi
—
ROE
-49.6%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $4
MGX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$25M
2023-12-31
→
2025-12-31
Hisse Başına Kâr
$-2.36
2023-12-31
→
2025-12-31
Serbest Nakit Akışı
$-89M
2024-12-31
→
2025-12-31
Marjlar
-348.5%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
MGX
Akran Ortalaması
P/E (TTM)
-0.7
0.9
P/S (TTM) (F/S (TTM))
2.4
2.0
P/B (F/D)
0.4
2.3
Price / FCF (Fiyat / Serbest Nakit Akışı)
-0.7
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
MGX
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-380.9%
—
Net Profit Margin (Net Kâr Marjı)
-348.5%
-350.0%
ROA
-32.2%
-69.7%
ROE
-49.6%
-112.4%
ROIC
-60.5%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
MGX
Akran Ortalaması
Current Ratio (Cari Oran)
7.2
2.4
Quick Ratio (Cari Oran)
1.8
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
MGX
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-51.8%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
MGX
Akran Ortalaması
MGX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
9 analist
- Güçlü Al 2 22,2%
- Al 5 55,6%
- Tut 2 22,2%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
3 analist · 2026-05-16
Medyan
$9.00
← Tüm hedeflerin altında
$1.26
Düşük
$7.00
Yüksek
$12.00
Medyan hedef
$9.00
+614,3%
Ortalama hedef
$9.33
+640,7%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.01%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.61 | $-0.53 | -0.08% |
| 31 Aralık 2025 | $-0.60 | $-0.61 | 0.01% |
| 30 Eylül 2025 | $-0.55 | $-0.59 | 0.04% |
| 30 Haziran 2025 | $-0.54 | $-0.63 | 0.09% |
| 31 Mart 2025 | $-0.68 | $-0.58 | -0.10% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| MGX | $61M | -0.7 | -51.8% | -348.5% | -49.6% | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
| ATYR | $77M | -1.0 | -19.1% | -39009.5% | -107.8% | — |
| KALA | $15M | -0.2 | — | — | -1423.8% | — |
| XLO | $3M | -0.2 | 589.9% | -80.0% | -165.5% | — |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | — |
| ESLA | — | -4.5 | — | — | — | — |
| GRML | — | — | — | — | -104.9% | — |
| PSTV | $71M | -1.8 | -10.5% | -429.4% | -636.9% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $25M | $52M | $45M | |
| R&D Expense | $94M | $109M | $94M | |
| SG&A Expense | $27M | $32M | $29M | |
| Operating Expenses | $121M | $141M | $123M | |
| Operating Income | $-96M | $-89M | $-78M | |
| Interest Income | $9M | $15M | $15M | |
| Other Non-op | $-91.0K | $-207.0K | $-74.0K | |
| Pretax Income | $-88M | $-84M | $-60M | |
| Income Tax | $-58.0K | $-6M | $8M | |
| Net Income | $-88M | $-78M | $-68M | |
| EPS (Basic) | $-2.36 | $-2.36 | $-20.05 | |
| EPS (Diluted) | $-2.36 | $-2.36 | $-20.05 | |
| Shares (Basic) | 37,251,050 | 33,027,889 | 3,404,585 | |
| Shares (Diluted) | 37,251,050 | 33,027,889 | 3,404,585 | |
| EBITDA | $-96M | $-89M | · |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $42M | $27M | $141M | |
| Receivables | $305.0K | $1M | $2M | |
| Prepaid Expense | $4M | $8M | $5M | |
| Current Assets | $166M | $258M | $278M | |
| PP&E (Net) | $12M | $18M | $22M | |
| PP&E (Gross) | $28M | $29M | $28M | |
| Accum. Depreciation | $16M | $11M | $6M | |
| Other Non-current Assets | $836.0K | $287.0K | $5M | |
| Total Assets | $221M | $325M | $365M | |
| Accounts Payable | $1M | $533.0K | $2M | |
| Current Liabilities | $23M | $37M | $69M | |
| Capital Leases | $35M | $40M | $45M | |
| Other Non-current Liabilities | $2M | $2M | $5M | |
| Total Liabilities | $63M | $90M | $150M | |
| Common Stock | $4.0K | $4.0K | $0 | |
| Paid-in Capital | $469M | $457M | $9M | |
| Retained Earnings | $-311M | $-223M | $-145M | |
| AOCI | $260.0K | $709.0K | $-97.0K | |
| Stockholders' Equity | $159M | $235M | $-136M | |
| Liabilities + Equity | $221M | $325M | $365M | |
| Shares Outstanding | 37,620,668 | 37,418,470 | 3,404,585 |
Nakit Akışı 8
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $12M | $16M | $7M | |
| Operating Cash Flow | $-89M | $-109M | $-91M | |
| CapEx | $574.0K | $3M | $10M | |
| Investing Cash Flow | $104M | $-88M | $46M | |
| Financing Cash Flow | $-356.0K | $84M | $1M | |
| Net Change in Cash | $14M | $-113M | $-45M | |
| Taxes Paid | $-2M | $4M | $2M | |
| Free Cash Flow | $-89M | $-112M | · |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -380.9% | -170.0% | · | |
| Net Margin | -348.5% | -149.3% | · | |
| Pretax Margin | -348.8% | -159.8% | · | |
| EBITDA Margin | -380.9% | -170.0% | · | |
| ROA | -32.2% | -22.6% | · | |
| ROE | -49.6% | -31.8% | · | |
| ROIC | -60.5% | -35.4% | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.2 | 6.9 | · | |
| Quick Ratio | 1.8 | 0.8 | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | |
| Receivables Turnover | 32.3 | 28.2 | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | -51.8% | 16.8% | · |
Değerleme (TTM) 10
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $25M | $52M | $45M | |
| Net Income TTM | $-88M | $-78M | $-68M | |
| Market Cap | $61M | $135M | · | |
| P/E | -0.7 | -1.5 | · | |
| P/S | 2.4 | 2.6 | · | |
| P/B | 0.4 | 0.6 | · | |
| P / Tangible Book | 0.4 | 0.6 | · | |
| P / Cash Flow | -0.7 | -1.2 | · | |
| P / FCF | -0.7 | -1.2 | · | |
| Earnings Yield | -145.7% | -65.4% | · |
Gelir Tablosu 15
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $4M | $9M | $9M | $4M | $10M | $12M | $20M | $11M | $12M | $12M | $11M | $9M | |
| R&D Expense | $19M | $22M | $25M | $23M | $25M | $23M | $26M | $28M | $31M | $25M | $27M | $23M | $20M | |
| SG&A Expense | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $9M | $9M | $8M | $8M | $7M | $6M | |
| Operating Expenses | $26M | $28M | $31M | $30M | $32M | $30M | $34M | $37M | $40M | $33M | $35M | $29M | $27M | |
| Operating Income | $-25M | $-24M | $-23M | $-21M | $-28M | $-21M | $-22M | $-17M | $-29M | $-20M | $-22M | $-18M | $-18M | |
| Interest Income | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-op | $-1.0K | $-11.0K | $-2.0K | $-70.0K | $-8.0K | $-49.0K | $-57.0K | $-51.0K | $-50.0K | $-4.0K | $-85.0K | $16.0K | $-1.0K | |
| Pretax Income | $-23M | $-22M | $-21M | $-20M | $-25M | $-25M | $-21M | $-13M | $-25M | $-17M | $-19M | $-11M | $-14M | |
| Income Tax | $10.0K | $34.0K | $-234.0K | $44.0K | $98.0K | $-1M | $-2M | $-2M | $0 | $7M | $1M | $2M | $-2M | |
| Net Income | $-23M | $-23M | $-20M | $-20M | $-25M | $-23M | $-19M | $-11M | $-25M | $-19M | $-20M | $-13M | $-16M | |
| EPS (Basic) | $-0.61 | $-0.59 | $-0.55 | $-0.54 | $-0.68 | $-0.37 | $-0.51 | $-0.29 | $-1.19 | $-5.67 | $-5.82 | $-3.82 | $-4.74 | |
| EPS (Diluted) | $-0.61 | $-0.59 | $-0.55 | $-0.54 | $-0.68 | $-0.37 | $-0.51 | $-0.29 | $-1.19 | $-5.67 | $-5.82 | $-3.82 | $-4.74 | |
| Shares (Basic) | 37,581,094 | -74,274,405 | 37,349,449 | 37,156,979 | 37,019,027 | -61,501,579 | 36,766,309 | 36,625,291 | 21,137,868 | -6,809,170 | 3,404,585 | 3,404,585 | 3,404,585 | |
| Shares (Diluted) | 37,581,094 | -74,274,405 | 37,349,449 | 37,156,979 | 37,019,027 | -61,501,579 | 36,766,309 | 36,625,291 | 21,137,868 | -6,809,170 | 3,404,585 | 3,404,585 | 3,404,585 | |
| EBITDA | $-25M | · | $-23M | $-21M | $-28M | · | $-22M | $-17M | $-29M | · | · | · | · |
Bilanço 21
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $42M | $33M | $27M | $29M | $27M | $25M | $61M | $103M | $141M | · | · | · | |
| Receivables | $0 | $305.0K | $960.0K | $900.0K | $900.0K | $1M | $589.0K | $2M | $2M | $2M | · | · | · | |
| Prepaid Expense | $4M | $4M | $5M | $6M | $6M | $8M | $7M | $6M | $6M | $5M | · | · | · | |
| Current Assets | $145M | $166M | $190M | $212M | $233M | $258M | $282M | $308M | $336M | $278M | · | · | · | |
| PP&E (Net) | $11M | $12M | $14M | $15M | $17M | $18M | $20M | $21M | $21M | $22M | · | · | · | |
| PP&E (Gross) | · | $28M | · | · | · | $29M | · | · | · | $28M | · | · | · | |
| Accum. Depreciation | · | $16M | · | · | · | $11M | · | · | · | $6M | · | · | · | |
| Other Non-current Assets | $927.0K | $836.0K | $809.0K | $805.0K | $781.0K | $287.0K | $320.0K | $332.0K | $379.0K | $5M | · | · | · | |
| Total Assets | $197M | $221M | $248M | $272M | $298M | $325M | $358M | $386M | $415M | $365M | · | · | · | |
| Accounts Payable | $2M | $1M | $1M | $3M | $3M | $533.0K | $3M | $3M | $7M | $2M | · | · | · | |
| Current Liabilities | $22M | $23M | $30M | $33M | $40M | $37M | $46M | $53M | $71M | $69M | · | · | · | |
| Capital Leases | $33M | $35M | $36M | $37M | $39M | $40M | $41M | $43M | $44M | $45M | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | · | · | · | |
| Total Liabilities | $59M | $63M | $69M | $76M | $85M | $90M | $103M | $116M | $140M | $150M | · | · | · | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $0 | · | · | · | |
| Paid-in Capital | $472M | $469M | $466M | $463M | $460M | $457M | $454M | $451M | $446M | $9M | · | · | · | |
| Retained Earnings | $-334M | $-311M | $-288M | $-268M | $-248M | $-223M | $-200M | $-181M | $-170M | $-145M | · | · | · | |
| AOCI | $-44.0K | $260.0K | $371.0K | $372.0K | $621.0K | $709.0K | $2M | $-265.0K | $-278.0K | $-97.0K | · | · | · | |
| Stockholders' Equity | $138M | $159M | $178M | $196M | $213M | $235M | $256M | $269M | $276M | $-136M | · | · | · | |
| Liabilities + Equity | $197M | $221M | $248M | $272M | $298M | $325M | $358M | $386M | $415M | $365M | · | · | · | |
| Shares Outstanding | 37,647,057 | 37,620,668 | 37,546,751 | 37,533,136 | 37,382,478 | 37,418,470 | 37,432,832 | 37,459,853 | 37,468,078 | 3,404,585 | · | · | · |
Nakit Akışı 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $2M | $3M | $656.0K | $529.0K | |
| Operating Cash Flow | $-21M | $-24M | $-21M | $-21M | $-23M | $-26M | $-27M | $-26M | $-30M | $-21M | $-24M | $-26M | $-21M | |
| CapEx | $25.0K | $85.0K | $74.0K | $127.0K | $288.0K | $334.0K | $1M | $665.0K | $915.0K | $2M | $2M | $3M | $3M | |
| Investing Cash Flow | $4M | $32M | $27M | $19M | $25M | $29M | $-9M | $-13M | $-95M | $61M | $76M | $-19M | $-72M | |
| Financing Cash Flow | $-27.0K | $74.0K | $-187.0K | $-166.0K | $-77.0K | $0 | $-492.0K | $-2M | $87M | $-1M | $-2M | $-39.0K | $4M | |
| Net Change in Cash | $-17M | $9M | $6M | $-2M | $2M | $2M | $-36M | $-41M | $-38M | $39M | $50M | $-45M | $-89M | |
| Free Cash Flow | $-21M | · | · | · | $-23M | · | · | · | $-31M | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1970.1% | · | -263.8% | -246.5% | -674.1% | · | -194.4% | -84.3% | -260.2% | · | · | · | · | |
| Net Margin | -1847.7% | · | -235.5% | -233.8% | -606.7% | · | -163.0% | -53.7% | -225.4% | · | · | · | · | |
| Pretax Margin | -1846.9% | · | -238.2% | -233.3% | -604.3% | · | -181.3% | -64.7% | -225.4% | · | · | · | · | |
| EBITDA Margin | -1970.1% | · | -263.8% | -246.5% | -674.1% | · | -194.4% | -84.3% | -260.2% | · | · | · | · | |
| ROA | -9.3% | · | -6.7% | -6.0% | -7.0% | · | -10.5% | -5.6% | -12.1% | · | · | · | · | |
| ROE | -13.2% | · | -9.4% | -8.6% | -10.3% | · | -14.7% | -8.0% | -18.2% | · | · | · | · | |
| ROIC | -17.8% | · | -12.7% | -10.7% | -13.1% | · | -7.9% | -5.2% | -10.5% | · | · | · | · |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.4 | · | 6.4 | 6.4 | 5.8 | · | 6.2 | 5.8 | 4.7 | · | · | · | · | |
| Quick Ratio | 1.1 | · | 1.1 | 0.8 | 0.8 | · | 0.6 | 1.2 | 1.5 | · | · | · | · |
Verimlilik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Receivables Turnover | 2.8 | · | 11.2 | 6.7 | 2.8 | · | 39.1 | 24.3 | 10.7 | · | · | · | · |
Değerleme (TTM) 10
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $23M | · | $33M | $44M | $47M | · | $55M | $55M | $44M | · | · | · | · | |
| Net Income TTM | $-88M | · | $-84M | $-74M | $-80M | · | $-74M | $-69M | $-74M | · | · | · | · | |
| Market Cap | $50M | · | $89M | $56M | $51M | · | $81M | $153M | $395M | · | · | · | · | |
| P/E | -0.6 | · | -1.0 | -0.7 | -0.5 | · | -0.3 | -0.4 | -0.7 | · | · | · | · | |
| P/S | 2.2 | · | 2.7 | 1.3 | 1.1 | · | 1.5 | 2.8 | 9.1 | · | · | · | · | |
| P/B | 0.4 | · | 0.5 | 0.3 | 0.2 | · | 0.3 | 0.6 | 1.4 | · | · | · | · | |
| P / Tangible Book | 0.4 | · | 0.5 | 0.3 | 0.2 | · | 0.3 | 0.6 | 1.4 | · | · | · | · | |
| P / Cash Flow | -2.4 | · | · | · | -2.2 | · | · | · | -13.2 | · | · | · | · | |
| P / FCF | -2.4 | · | · | · | -2.2 | · | · | · | -12.8 | · | · | · | · | |
| Earnings Yield | -177.6% | · | -96.2% | -136.5% | -196.3% | · | -359.9% | -272.5% | -147.6% | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Gelir | $25M | $52M | $45M |
| Faaliyet Kâr Marjı % | -380.9% | -170.0% | — |
| Net Gelir | $-88M | $-78M | $-68M |
| Seyreltilmiş Hisse Başı Kâr | $-2.36 | $-2.36 | $-20.05 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Cari Oran | 7.2 | 6.9 | — |
| Cari Oran | 1.8 | 0.8 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Serbest Nakit Akışı | $-89M | $-112M | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.